Bölümler
-
โถ๏ธ๐ง๐๏ธPART 2! Tools to use on the frontline and tips to engage your patients in 60 seconds or less. We untangle the complex web of the COVID-19 pandemic and plot a course for the journey ahead with ๐๐ซ.Alan Kaplan and Dr.Marla Shapiro who break down all you need to know.
โ๏ธโ๏ธWe take an in-depth look at the unfolding chapter of the COVID-19 pandemic. The World Health Organization (WHO) has declared the global health emergency phase over, yet COVID-19 remains a persistent adversary. . Seems like a contradiction, right? We're dissecting this communique and explore how to break it down on the frontlines. We ask, where are we headed now?
โ๏ธโ๏ธWe delve into the questions on everyone's mind: Do our current vaccines shield us against the elusive XBB.1.16 variant? What does the end of the 'emergency phase' actually mean for us on a day-to-day basis? And with the virus still lurking in our midst, how do we navigate this new landscape of coexistence?
โ๏ธโ๏ธWe examine the WHO's Technical Advisory Group (TAG) proposal to retire the original COVID-19 strain from future vaccines and explore what this could mean for the future of public vaccination strategies.
โ๏ธโ๏ธWe're also talking the latest research on hybrid immunity and how to translate this for your patients in a meaningful way. What happens when natural infection immunity meets vaccine-induced immunity? Does this 'hybrid immunity' offer us an extra layer of protection?
โ๏ธโ๏ธKeeping the conversation light, the information insightful, and the health advice actionable to navigate the road ahead.
Letโs dive in!
Dr.Alan Kaplan
Dr.Alan Kaplan, MD, CCFP(EM), CPC(HC) is a family Physician practicing in York Region, Ontario, Canada.
Regional Primary Care Lead, Central Regional Cancer Program
Chairperson of the Family Physician Airways Group of Canada
Alan is a practicing family physician and the Medical director of LHIN Pulmonary Rehabilitation clinics in Ontario, Canada. Alan chairs the Family Physician Airways Group of Canada (www.fpagc.com) and is also an Honorary Professor of Primary Care Respiratory Medicine of the Observational and Pragmatic Research Institute, Singapore.
Alanโs other positions include Co-Chair of the Health Quality Ontario COPD Community Management standards committee, Member of the Health Quality Ontario Asthma community management standards committee, Vice President Respiratory Effectiveness Group and Senate member of the International Primary Care Respiratory Group
Alan is also a Clinical Lecturer at the University of Toronto in the Department of Family and Community Medicine, while being a Member of the Physician Advisory Panel of the Medical Post, the Medical Advisory Committee of the Pulmonary Hypertension Association of Canada and a Member of Section of Allergy and Respiratory Therapeutics, Health Canada. Alan has authored 136 Peer Reviewed Articles and 104 Conference Abstracts.
Dr. Marla Shapiro C.M., CCFP, MHSc, FRCPC, FCFP, NCMP
Professor, DFCM, University of Toronto
Dr. Shapiro completed medical school at McGill University and trained at the University of Toronto for her Masters of Health Science. She concluded her specialty training in Community Medicine, receiving her Fellowship in Preventive Medicine and Public Health from the Royal College of Physicians and Surgeons of Canada. She also holds a Fellowship in Family Medicine and is currently a Professor in the Department of Family and Community Medicine at the University of Toronto. She is a credentialed expert in Menopause from the North American Menopause Society.
Dr. Shapiro is seen on CTV NewsChannel as the medical expert. She is the author of the bestselling book, Life in the Balance: My Journey with Breast Cancer.
Dr. Shapiro is a member of several advisory boards, having been a member of the Canadian Partnership Against Cancer, Research Canada and the Board of Trustees of the North American Menopause Society. She was the President of the North American Menopause Society in 2017 and the Scientific Chair of the 25th anniversary of NAMS.
Currently she sits on the Board of the Terry Fox Research Institute and the Board of Trustees of the International Menopause Society. She received an Award of Excellence from the College of Family Physicians of Canada, and was awarded the Excellence in Creative Professional Activity by the University of Toronto. Dr. Shapiro was also chosen in the top 10 of the 50 most powerful doctors in Canada by the Medical Post. In 2015 Dr. Shapiro was named a Member of the Order of Canada for her contributions as a family physician and trusted source of health information. One of this countryโs highest civilian honours, the Order of Canada recognizes outstanding achievement, dedication to the community, and service to the nation.
Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant
-
โถ๏ธ๐ง๐๏ธToday we untangle the complex web of the COVID-19 pandemic and plot a course for the journey ahead with ๐๐ซ.Alan Kaplan and Dr.Marla Shapiro who break down all you need to know.
โ๏ธโ๏ธWe take an in-depth look at the unfolding chapter of the COVID-19 pandemic. The World Health Organization (WHO) has declared the global health emergency phase over, yet COVID-19 remains a persistent adversary. . Seems like a contradiction, right? We're dissecting this communique and explore how to break it down on the frontlines. We ask, where are we headed now?
โ๏ธโ๏ธWe delve into the questions on everyone's mind: Do our current vaccines shield us against the elusive XBB.1.16 variant? What does the end of the 'emergency phase' actually mean for us on a day-to-day basis? And with the virus still lurking in our midst, how do we navigate this new landscape of coexistence?
โ๏ธโ๏ธWe examine the WHO's Technical Advisory Group (TAG) proposal to retire the original COVID-19 strain from future vaccines and explore what this could mean for the future of public vaccination strategies.
โ๏ธโ๏ธWe're also talking the latest research on hybrid immunity and how to translate this for your patients in a meaningful way. What happens when natural infection immunity meets vaccine-induced immunity? Does this 'hybrid immunity' offer us an extra layer of protection?
โ๏ธโ๏ธKeeping the conversation light, the information insightful, and the health advice actionable to navigate the road ahead.
Letโs dive in!
Dr.Alan Kaplan
Dr.Alan Kaplan, MD, CCFP(EM), CPC(HC) is a family Physician practicing in York Region, Ontario, Canada.
Regional Primary Care Lead, Central Regional Cancer Program
Chairperson of the Family Physician Airways Group of Canada
Alan is a practicing family physician and the Medical director of LHIN Pulmonary Rehabilitation clinics in Ontario, Canada. Alan chairs the Family Physician Airways Group of Canada (www.fpagc.com) and is also an Honorary Professor of Primary Care Respiratory Medicine of the Observational and Pragmatic Research Institute, Singapore.
Alanโs other positions include Co-Chair of the Health Quality Ontario COPD Community Management standards committee, Member of the Health Quality Ontario Asthma community management standards committee, Vice President Respiratory Effectiveness Group and Senate member of the International Primary Care Respiratory Group
Alan is also a Clinical Lecturer at the University of Toronto in the Department of Family and Community Medicine, while being a Member of the Physician Advisory Panel of the Medical Post, the Medical Advisory Committee of the Pulmonary Hypertension Association of Canada and a Member of Section of Allergy and Respiratory Therapeutics, Health Canada. Alan has authored 136 Peer Reviewed Articles and 104 Conference Abstracts.
Dr. Marla Shapiro C.M., CCFP, MHSc, FRCPC, FCFP, NCMP
Professor, DFCM, University of Toronto
Dr. Shapiro completed medical school at McGill University and trained at the University of Toronto for her Masters of Health Science. She concluded her specialty training in Community Medicine, receiving her Fellowship in Preventive Medicine and Public Health from the Royal College of Physicians and Surgeons of Canada. She also holds a Fellowship in Family Medicine and is currently a Professor in the Department of Family and Community Medicine at the University of Toronto. She is a credentialed expert in Menopause from the North American Menopause Society.
Dr. Shapiro is seen on CTV NewsChannel as the medical expert. She is the author of the bestselling book, Life in the Balance: My Journey with Breast Cancer.
Dr. Shapiro is a member of several advisory boards, having been a member of the Canadian Partnership Against Cancer, Research Canada and the Board of Trustees of the North American Menopause Society. She was the President of the North American Menopause Society in 2017 and the Scientific Chair of the 25th anniversary of NAMS.
Currently she sits on the Board of the Terry Fox Research Institute and the Board of Trustees of the International Menopause Society. She received an Award of Excellence from the College of Family Physicians of Canada, and was awarded the Excellence in Creative Professional Activity by the University of Toronto. Dr. Shapiro was also chosen in the top 10 of the 50 most powerful doctors in Canada by the Medical Post. In 2015 Dr. Shapiro was named a Member of the Order of Canada for her contributions as a family physician and trusted source of health information. One of this countryโs highest civilian honours, the Order of Canada recognizes outstanding achievement, dedication to the community, and service to the nation.
-
Eksik bölüm mü var?
-
๐๏ธ๐๏ธ๐๏ธ ๏ธ ๐๐ข๐ ๐๐๐ฐ๐ฌ ๐๐ซ๐จ๐ฆ ๐ญ๐ก๐ ๐ก๐๐๐ซ๐ญ ๐จ๐ ๐๐๐ง๐๐๐'๐ฌ ๐๐๐ฉ๐ข๐ญ๐๐ฅ! ๐
๐๐'๐ซ๐ ๐ญ๐ก๐ซ๐ข๐ฅ๐ฅ๐๐ ๐ญ๐จ ๐๐ง๐ง๐จ๐ฎ๐ง๐๐ ๐ญ๐ก๐๐ญ ๐ฐ๐'๐ซ๐ ๐ฅ๐๐ฎ๐ง๐๐ก๐ข๐ง๐ ๐ ๐ฉ๐จ๐๐๐๐ฌ๐ญ ๐ฌ๐๐ซ๐ข๐๐ฌ ๐ฌ๐ญ๐ซ๐๐ข๐ ๐ก๐ญ ๐๐ซ๐จ๐ฆ ๐๐ญ๐ญ๐๐ฐ๐, ๐๐ซ๐จ๐๐๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐ฅ๐ฅ ๐ญ๐ก๐ ๐๐๐ญ๐ข๐จ๐ง ๐๐ง๐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐๐ซ๐จ๐ฆ ๐๐๐ ๐๐๐๐.
๐๐ก๐ข๐ฌ ๐๐ฉ๐ข๐ฌ๐จ๐๐ ๐ข๐ฌ ๐ฒ๐จ๐ฎ๐ซ ๐๐ฅ๐ฅ-๐๐๐๐๐ฌ๐ฌ ๐ฉ๐๐ฌ๐ฌ ๐ญ๐จ ๐ ๐๐ฎ๐ซ๐๐ญ๐๐ ๐ฌ๐๐ฅ๐๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐ ๐ฌ๐ก๐จ๐ซ๐ญ ๐๐จ๐ง๐ฏ๐๐ซ๐ฌ๐๐ญ๐ข๐จ๐ง๐ฌ ๐ฐ๐ข๐ญ๐ก ๐๐ฅ๐ข๐ง๐ข๐๐ข๐๐ง ๐ญ๐ก๐จ๐ฎ๐ ๐ก๐ญ ๐ฅ๐๐๐๐๐ซ๐ฌ ๐๐ง๐ ๐ ๐๐ฆ๐ ๐๐ก๐๐ง๐ ๐๐ซ๐ฌ ๐ฐ๐ก๐จ ๐๐ซ๐ ๐ฌ๐ก๐๐ฉ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐ฎ๐ญ๐ฎ๐ซ๐ ๐จ๐ ๐ฉ๐ฎ๐๐ฅ๐ข๐ ๐ก๐๐๐ฅ๐ญ๐ก ๐๐ง๐ ๐๐๐ฒ๐จ๐ง๐.
๐๐ช๐ฃ๐ ๐๐ฃ, ๐ฉ๐ช๐ง๐ฃ ๐ช๐ฅ ๐ฉ๐๐ ๐ซ๐ค๐ก๐ช๐ข๐, ๐๐ฃ๐ ๐ฉ๐ง๐๐ฃ๐จ๐๐ค๐ง๐ข ๐ฉ๐ค๐๐๐ฉ๐๐๐ง. ๐ง #๐พ๐๐พ2023 #๐๐ค๐๐๐๐จ๐ฉ #๐๐ฉ๐ฉ๐๐ฌ๐
๐๏ธ๐๏ธ๐๏ธ MINI EPISODE 1: A Conversation with Dr.Sonia Anand MD, PhD, FRCPC
๐ก ๐ก ๐กEnsuring immunization of structurally disadvantaged populations: Black People and other people of colour
Podcast Learning objectives
โข Describe how race-disaggregated data can allow for more targeted, community-specific interventions. โข Apply novel community-specific work to engage communities to support immunization. โข Illustrate how anti-Black racism presents a pervasive barrier to engaging with preventive health care initiatives.For this mini podcast, we delve into how historical and systemic racism creates hurdles not only in understanding vaccine coverage discrepancies in Canada, but also in crafting effective, nuanced responses. We spotlight the distinctive obstacles Black and Asian communities in Canada have faced in accessing vaccines, both amidst the pandemic and prior to it. In the absence of detailed race-specific data for monitoring diseases preventable by vaccines and tracking vaccination rates, it is difficult to adequately cater to marginalized communities who face systemic barriers to healthcare access, including vaccinations. Dr.Anand unpacks this complex issue.
About Dr.Sonia Anand MD, PhD, FRCPC
Professor of Medicine and Epidemiology, McMasterSenior Scientist Population Health Research InstituteTier 1 Canada Research Chair in Ethnic Diversity and Cardiovascular DiseaseHeart and Stroke Chair in Population HealthAssociate Chair of Equity and Diversity, Department of MedicineDirector of Chanchlani Research CentreDr. Sonia Anand is a professor in the Department of Medicine, and the Director of the Population Genomics Program, at McMaster. She is also a senior scientist at the Population Health Research Institute at Hamilton Health Sciences. Dr. Anand holds a Canada Research Chair in Ethnic Diversity and Cardiovascular Disease, and the Heart and Stroke Foundation of Ontario/Michael G. DeGroote Chair in Population Health Research. In 2010, Dr. Anand was named among the top 100 women by the Womenโs Executive Network for her accomplishments in research and medicine. Her current research focuses on environmental and genetic determinants of vascular disease in populations of varying ancestral origin, women and cardiovascular disease.
๐๏ธ๐๏ธ๐๏ธ MINI EPISODE 2: A Conversation with Dr.Wayne Ghesquiere MD, FRCPC
๐ก ๐ก ๐กLong-term protection against herpes zoster by the adjuvanted recombinant zoster vaccine: Interim efficacy, immunogenicity and safety results at approximately 10 years after initial vaccination
Podcast Learning objectives
โข Discuss the interim efficacy of the adjuvanted recombinant zoster vaccine approximately 10 years post-vaccination.โข Explain the immunogenicity of the adjuvanted recombinant zoster vaccine and how it contributes to its long-term protection against herpes zoster.โข Evaluate the safety profile of the adjuvanted recombinant zoster vaccine based on data collected over approximately 10 years.โข Analyze the significance of these interim results in the context of long-term vaccine strategies against herpes zoster.โข Incorporate the provided insights into clinical practice and future research regarding herpes zoster vaccination strategies.โข Communicate effectively to patients about the long-term benefits and safety of the adjuvanted recombinant zoster vaccineAbout Dr.Wayne Ghesquire MD, FRCPC
Dr Wayne Ghesquiere is a Clinical Infectious Diseases, Tropical Diseases and Internal Medicine consultant in Victoria BC as well as the former section chief for infectious diseases with the Vancouver Island Health Authority, VIHA.
Wayne is a Clinical Assistant Professor of Medicine with University of British Columbia. Teaches internal medicine residents and infectious diseases fellows. He is an attending physician at the Royal Jubilee and the Victoria General Hospitals in Victoria, BC. He has an inpatient and a private outpatient practice in infectious diseases.
Wayne is the chair and organizer of the annual Infectious Diseases Update in Victoria now in itโs 26th year. He is also the medical director of the Nova Travel Medicine and Immunization Clinic in Victoria.
Current areas of interests include clinical research in Hepatitis B and C antiviral therapies, new vaccines, and teaching. He is a principal investigator of many clinical trials. He has publications in peer-reviewed medical journals including the NEJM, Lancet, Clinical Infectious Diseases, CMAJ, Open Medicine and others.
๐๏ธ๐๏ธ๐๏ธ MINI EPISODE 3: A Conversation with Dr. Juthaporn Cowan, MD, FRCPC
๐ก ๐ก ๐กManagement of COVID-19 in immunocompromised patients: Are you up to date?
This podcast episode is centered around COVID-19 protection strategies for immunocompromised patients. Additionally, listeners will gain up to date insight into the range of tools available for these patients' protection and treatment, including antivirals and both active and passive vaccination methods. We'll also tackle ongoing concerns regarding the management of COVID-19 amidst the persistent emergence of new variants, emphasizing the necessity of regular revisits and modifications to these management strategies.
Podcast Learning Objectives
Describe the medical challenges faced by immunocompromised patients and discuss the unmet need for additional protection against SARS โ CoV-2. Address the most recent data for prevention and treatment of COVID-19 in immunocompromised patients including the use of monoclonal antibodies. Share best practices for the optimum clinical management of COVID-19 in immunocompromised patients in the current Canadian context.About Dr. Juthaporn Cowan, MD, FRCPC
Assistant Professor, Associate Scientist, The Ottawa Hospital Research Institute
Dr.Juthaporn Cowan is an Associate Scientist at The Ottawa Hospital Research Institute, Assistant Professor at The University of Ottawa, cross-appointed Assistant Professor at the Department of Biochemistry, Microbiology and Immunology and a Physician for the Division of Infectious Diseases at The Ottawa Hospital.
Dr. Cowan began her training at Mahidol University in Thailand for her MD. She also obtained a PhD in Microbiology and Immunology at Kyoto University in Kyoto, Japan. She completed a Postdoctoral Fellowship at The Ottawa Hospital Research Institute. Her research at the time focused on Tuberculosis and immunopathogenesis. She then started her Internal Medicine training at the University of Ottawa. During her postgraduate training her interest shifted from tuberculosis to infection in immunodeficiency patients. Subsequently, she completed a Clinical Fellowship in Infectious Diseases with the University of Ottawa. Drs.D.William Cameron and Cowan run an immunodeficiency/immunoglobulin treatment clinic in Ottawa
-
๐๐๐ผ๐ฟ ๐๐ฎ๐ป๐ฎ๐ฑ๐ถ๐ฎ๐ป๐, ๐ป๐ผ๐ ๐บ๐ผ๐ฟ๐ฒ ๐๐ต๐ฎ๐ป ๐ฒ๐๐ฒ๐ฟ, ๐ฎ๐ฐ๐ฐ๐ฒ๐๐ ๐๐ผ ๐๐ถ๐บ๐ฒ๐น๐, ๐พ๐๐ฎ๐น๐ถ๐๐ ๐ต๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ ๐ถ๐ ๐๐ผ๐ฝ ๐ผ๐ณ ๐บ๐ถ๐ป๐ฑ.
๐๐ง๐ต๐ฒ ๐๐ฎ๐ป๐ฎ๐ฑ๐ฎ ๐๐ฒ๐ฎ๐น๐๐ต ๐๐ฐ๐, ๐๐ต๐ถ๐ฐ๐ต ๐ผ๐๐๐น๐ถ๐ป๐ฒ๐ ๐๐ต๐ฒ ๐ป๐ฎ๐๐ถ๐ผ๐ป๐ฎ๐น ๐ฝ๐ฟ๐ถ๐ป๐ฐ๐ถ๐ฝ๐น๐ฒ๐ ๐๐ต๐ฎ๐ ๐ด๐ผ๐๐ฒ๐ฟ๐ป ๐๐ต๐ฒ ๐๐ฎ๐ป๐ฎ๐ฑ๐ถ๐ฎ๐ป ๐ต๐ฒ๐ฎ๐น๐๐ต ๐๐๐๐๐ฒ๐บ, ๐๐ฎ๐ ๐ฒ๐๐๐ฎ๐ฏ๐น๐ถ๐๐ต๐ฒ๐ฑ ๐ถ๐ป ๐ญ๐ต๐ด๐ฐ.
โถ๏ธ๐ ๐น๐ผ๐ ๐ต๐ฎ๐ ๐ฐ๐ต๐ฎ๐ป๐ด๐ฒ๐ฑ ๐๐ถ๐ป๐ฐ๐ฒ ๐๐ต๐ฒ๐ป.
๐ก๐ก ๐ก๐ก ๐ฟ๐ค ๐ฌ๐ ๐ฃ๐๐๐ ๐ฉ๐ค ๐จ๐ฉ๐๐ฅ ๐๐๐๐ ๐๐ฃ๐ ๐๐๐ซ๐ ๐ฉ๐๐ ๐๐ค๐ช๐ง๐๐๐ ๐ฉ๐ค ๐ง๐๐ฉ๐๐๐ฃ๐ ๐๐๐ง๐ ๐๐๐ก๐๐ซ๐๐ง๐ฎ ๐๐ฃ ๐ฉ๐๐๐จ ๐๐ค๐ช๐ฃ๐ฉ๐ง๐ฎ ๐ฉ๐ค ๐ง๐๐๐ก๐๐๐ฉ ๐ฉ๐๐ ๐๐๐๐ฃ๐๐๐ฃ๐ ๐๐๐๐ก๐ฉ๐ ๐ฃ๐๐๐๐จ ๐ค๐ ๐พ๐๐ฃ๐๐๐๐๐ฃ๐จ? ๐๐จ ๐ข๐ค๐ง๐ ๐ข๐ค๐ฃ๐๐ฎ ๐๐ค๐๐ฃ๐ ๐ฉ๐ค ๐จ๐ค๐ก๐ซ๐ ๐ฉ๐๐ ๐ฅ๐ง๐ค๐๐ก๐๐ข?
๐ง๐ต๐ฒ ๐ฟ๐ถ๐๐ธ๐ถ๐ฒ๐๐ ๐ฐ๐ต๐ผ๐ถ๐ฐ๐ฒ ๐๐ผ๐บ๐ฒ๐๐ถ๐บ๐ฒ๐ ๐ถ๐ ๐๐ผ ๐๐i๐ฐ๐ธ ๐๐ถ๐๐ต ๐๐ต๐ฒ ๐๐๐ฎ๐๐๐ ๐พ๐๐ผ, ๐ฒ๐๐ฝ๐ฒ๐ฐ๐ถ๐ฎ๐น๐น๐ ๐๐ต๐ฒ๐ป ๐๐ฒ ๐๐ฝ๐ฒ๐ฎ๐ธ ๐ผ๐ณ ๐ต๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ.
๐๐ฌ The premiers and the prime minister reached a new 10 year healthcare funding deal totaling $196 billion, with $46 billion in new funding with a tailored approach to the unique healthcare needs of each province and territory via bilateral deals. Provinces and territories in return must commit to health-care reform and improve transparency around data collection.
๐โถ๏ธ We sit down with Canadian Prime Minister, Justin Trudeau, to chat about his vision for healthcare, opportunities and challenges, and what building accountability and innovation into these new bilateral healthcare agreements with each province and territory will, and can look like.
๐๐๏ธ ๐จ๏ธ Whether you practice in BC or Newfoundland, ๐ฌ๐๐๐ฉ๐๐๐ง ๐ฎ๐ค๐ช'๐ง๐ ๐ pharmacist, physician, nurse, nurse practitioner, or allied health professional, tune in to hear the PMโs personal message for our listeners and how the next generation of leaders in healthcare can play a meaningful role in shaping future of our healthcare system.
The Right Honourable Justin Trudeau, Prime Minister of Canada
Justin Trudeau is Canadaโs 23rd Prime Minister.
Justinโs vision of Canada is a country where everyone has a real and fair chance to succeed. His experiences as a teacher, father, leader, and advocate for youth have shaped his dedication to Canadians โ and his commitment to make Canada a place where everyone has the opportunities they need to thrive.
The oldest of three boys, Justin grew up with the profound influence of his father, Pierre Elliott Trudeau, and his mother, Margaret Trudeau. He was raised speaking both French and English and has family roots in both Eastern and Western Canada. This background helped spark his passion for public service and shaped his conviction that diversity is Canadaโs strength.
Justin studied literature at McGill University, graduating with a Bachelor of Arts (B.A.) in 1994. He went on to complete the University of British Columbiaโs education program, and spent several years teaching French, math, and other subjects in Vancouver. Teaching allowed him to make a positive impact in the lives of young people. He remains committed to hearing the voices of young Canadians, from the classroom to Parliament Hill.
Before entering politics, Justin served as the Chair of Katimavik, on the board for the Canadian Avalanche Foundation, and as an advocate for young people and the environment. As a speaker at events and conferences around the country, he encouraged young people to engage with the issues important to them and participate as active citizens. These experiences made it increasingly clear to him that the issues young Canadians care about โ education, the environment, and their generation's economic prospects โ needed a stronger voice.
Justin entered politics to make change that would better serve all Canadians. In 2007, he built a community-based, grassroots campaign to win the Liberal Party nomination in the Montrรฉal riding of Papineau. He was elected in 2008, and re-elected in 2011, 2015, and 2019.
Justin was elected Leader of the Liberal Party in April 2013. His leadership campaign focused on building a new, truly national movement of progressive Canadians, bringing hundreds of thousands of Canadians into politics, most for the first time. He worked closely with his team to build a plan to create jobs, grow the economy, protect the environment, and strengthen the middle class. With Justinโs leadership, the Liberal plan emphasized fair economic opportunity for everyone, respect for and promotion of freedom and diversity, and a more democratic government that truly represents Canadians.
On October 19, 2015, Justin led his party to victory, winning a majority government with seats in every province and territory across the country. He was sworn in on November 4, 2015.
On October 21, 2019, Justin led the Liberal Party to re-election, earning a second mandate from Canadians.
As Prime Minister, Justin leads a government that works hard every day to continue moving Canada forward. His team is focused on creating good middle class jobs, making life more affordable, keeping Canadaโs communities safe, fighting climate change, and moving forward on reconciliation with Indigenous peoples. A proud feminist, Justin appointed Canadaโs first gender balanced Cabinet.
-
๐ฌNOTE: Episode recorded in early Fall (September) as leadership candidate prior to David officially becoming Premier. ******
โ๏ธ Today, David Eby was sworn in as British Columbiaโs 37th premier.
๐จ๏ธ We sit down with Premier Eby to discuss his plans for the Province's #๐ต๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ ๐๐๐๐๐ฒ๐บ, ๐ถ๐ป๐ฐ๐น๐๐ฑ๐ถ๐ป๐ด everything from ๐ฒ๐ป๐ต๐ฎ๐ป๐ฐ๐ถ๐ป๐ด #patient ๐ฎ๐ฐ๐ฐ๐ฒ๐๐ by expanding ๐๐ต๐ฒ ๐๐๐ถ๐๐ฒ ๐ผ๐ณ ๐๐ฒ๐ฟ๐๐ถ๐ฐ๐ฒ๐ #๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ถ๐๐๐ ๐ฎ๐ป๐ฑ ๐ผ๐๐ต๐ฒ๐ฟ #๐๐๐ฃ๐ ๐ฐ๐ผ๐๐น๐ฑ ๐ฝ๐ฟ๐ผ๐๐ถ๐ฑ๐ฒ, reforming primary care, and if outdated legislation around patient rights is meeting the needs of today's patients.
๐ฌ ๐๏ธ ๐๐'๐ ๐ป๐ผ๐ ๐ฑ๐ถ๐ณ๐ณ๐ถ๐ฐ๐๐น๐ ๐๐ผ ๐ฎ๐ฟ๐ด๐๐ฒ ๐๐ต๐ฎ๐ ๐ฎ ๐๐ฟ๐ฎ๐ฑ๐ถ๐๐ถ๐ผ๐ป๐ฎ๐น ๐บ๐ถ๐ป๐ฑ๐๐ฒ๐ ๐ฐ๐ฎ๐ป ๐ฏ๐ฒ ๐ฐ๐ต๐ฎ๐น๐น๐ฒ๐ป๐ด๐ถ๐ป๐ด ๐๐ผ ๐๐ฎ๐ฐ๐ธ๐น๐ฒ ๐๐ต๐ฒ๐ป ๐๐ฒ ๐๐ต๐ถ๐ป๐ธ ๐ฎ๐ฏ๐ผ๐๐ #๐ต๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ ๐ฑ๐ฒ๐น๐ถ๐๐ฒ๐ฟ๐ ๐ฎ๐ป๐ฑ ๐ฝ๐ฎ๐๐ถ๐ฒ๐ป๐ ๐ฐ๐ฒ๐ป๐๐ฒ๐ฟ๐ฒ๐ฑ ๐ฐ๐ฎ๐ฟ๐ฒ ๐ถ๐ป ๐๐ฎ๐ป๐ฎ๐ฑ๐ฎ. ๐๐ป ๐ฎ ๐๐ถ๐บ๐ฒ ๐ผ๐ณ ๐ฐ๐ฟ๐ถ๐๐ถ๐, ๐ฑ๐ผ ๐๐ฒ ๐ป๐ฒ๐ฒ๐ฑ ๐ฎ ๐ณ๐๐ป๐ฑ๐ฎ๐บ๐ฒ๐ป๐๐ฎ๐น ๐๐ต๐ถ๐ณ๐ ๐ฎ๐ฏ๐ผ๐๐ ๐ต๐ผ๐ ๐๐ฒ ๐๐ต๐ถ๐ป๐ธ ๐ฎ๐ฏ๐ผ๐๐ #๐ฝ๐ฟ๐ถ๐บ๐ฎ๐ฟ๐ ๐ฐ๐ฎ๐ฟ๐ฒ ๐ฎ๐ป๐ฑ #๐ฝ๐ฎ๐๐ถ๐ฒ๐ป๐ ๐ฎ๐๐๐ฎ๐ฐ๐ต๐บ๐ฒ๐ป๐?
Questions we ask:
๐ก๐ก ๐ซ๐๐๐ ๐๐๐๐๐ ๐ช๐๐๐๐ ๐๐๐ ๐๐๐๐ ๐๐๐๐๐๐ ๐๐ ๐ ๐ฎ๐ท, ๐๐ ๐ ๐๐๐ ๐๐๐๐๐ ๐ช๐๐๐๐ ๐๐๐ ๐๐๐๐ ๐๐๐๐๐๐ ๐๐ ๐๐๐๐-๐๐๐๐๐๐๐ #๐๐๐๐๐๐๐ ๐๐๐๐ ๐๐๐๐๐๐๐๐-๐๐๐๐๐๐๐๐ ๐๐๐ ๐๐๐๐๐๐ ๐๐๐ ๐๐๐ ๐๐ ๐๐๐๐๐ #๐๐๐๐๐๐๐ ๐๐๐๐ service ๐๐๐๐ ๐๐๐๐? ๐ฌ๐ซ๐๐๐ ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐๐๐ ๐๐๐๐๐ ๐๐๐๐ ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐๐๐?
โถ๏ธ ๐ฐ๐ ๐ฐ ๐๐๐ 50 ๐๐๐๐๐๐๐๐ ๐๐๐ ๐๐๐ ๐๐๐ 20 ๐๐๐๐๐๐๐๐ ๐ ๐ ๐๐, ๐๐๐ ๐๐ ๐ ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐ #๐๐๐๐? ๐ฐ๐ ๐๐๐๐ ๐๐๐๐ ๐๐๐ ๐๐๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐ ๐๐๐? ๐ก๐ก ๐๐ถ๐ป๐ธ๐ถ๐ป๐ด #๐ต๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ #๐ฝ๐ฟ๐ผ๐๐ถ๐ฑ๐ฒ๐ฟ ๐ฟ๐ฒ๐บ๐๐ป๐ฒ๐ฟ๐ฎ๐๐ถ๐ผ๐ป ๐๐ถ๐๐ต ๐พ๐๐ฎ๐น๐ถ๐๐ ๐ผ๐ณ #๐ฐ๐ฎ๐ฟ๐ฒ, ๐๐ฒ๐ฟ๐๐ถ๐ฐ๐ฒ ๐ฑ๐ฒ๐น๐ถ๐๐ฒ๐ฟ๐ ๐บ๐ฒ๐๐ฟ๐ถ๐ฐ๐, ๐ฎ๐ป๐ฑ #๐ผ๐๐๐ฐ๐ผ๐บ๐ฒ๐ ๐ต๐ฎ๐ ๐ฏ๐ฒ๐ฒ๐ป ๐ฎ ๐ฐ๐ผ๐ป๐๐ฒ๐ฟ๐๐ฎ๐๐ถ๐ผ๐ป ๐๐ต๐ฎ๐'๐ ๐ฏ๐ฒ๐ฒ๐ป ๐ต๐ฎ๐ฑ ๐ณ๐ผ๐ฟ ๐๐ฒ๐ฎ๐ฟ๐ ๐ฎ๐ฐ๐ฟ๐ผ๐๐ ๐๐ฎ๐ป๐ฎ๐ฑ๐ฎ.๐จ๐ฆ
๐๏ธ๐ช๐ต๐ฎ๐ ๐๐ถ๐น๐น ๐ถ๐ ๐๐ฎ๐ธ๐ฒ ๐๐ผ ๐บ๐ฎ๐ธ๐ฒ ๐๐ต๐ฒ ๐๐ต๐ถ๐ณ๐ broadly across our healthcare ๐ณ๐ฟ๐ผ๐บ #๐๐ผ๐น๐๐บ๐ฒ ๐๐ผ #๐๐ฎ๐น๐๐ฒ ๐ฏ๐ฎ๐๐ฒ๐ฑ ๐ฐ๐ฎ๐ฟ๐ฒ and why are we not there yet?
ABOUT DAVID EBY, KC
David Eby, K.C.David Eby is the MLA for Vancouver-Point Grey, first elected in 2013.
Before he was elected, David was the Executive Director of the BC Civil Liberties Association, an adjunct professor of law at the University of British Columbia, president of the HIV/AIDS Legal Network, and served on the Vancouver Foundation's Health and Social Development Committee.
An award-winning human rights lawyer, he has been repeatedly recognized in local media as one of British Columbia's most effective advocates and has appeared at all levels of court in BC.
His years of legal advocacy at Pivot Legal Society to protect the human rights and dignity of homeless and under-housed residents of Vancouver's Downtown Eastside were recognized in 2011 by the UN Association in Canada and the B.C. Human Rights Coalition with their annual award.
-
โถ๏ธ ๐จ๏ธ We are excited to sit down with Canada's Chief Public Health Officer, Dr.Theresa Tam, to discuss her personal thoughts about how this pandemic has reshaped how we think about public health's role and new opportunities to synergize with frontline healthcare providers.
๐ฌ๐๏ธ Often climate change is not a top of mind issue when it comes to healthcare planning and resource allocation. In anticipation of Dr.Tam's upcoming Annual report, we deep dive into how public health is building in plans to address climate change, extreme weather event, and the changing endemicity of transmissible diseases as a result.
๐ก You also don't want to miss Dr.Tam's secret talent.
๐ฌNOTE: Links added below to Dr.Theresa Tam's Annual Report: Mobilizing Public Health Action on Climate Change in Canada as episode was recorded prior to release******
https://www.canada.ca/en/public-health/corporate/publications/chief-public-health-officer-reports-state-public-health-canada/state-public-health-canada-2022/report.html
--------
๐ข EPISODE TIME STAMPS๐ข
02:08 Intro
04:21 Dr.Tam's journey from practitioner to public health leader
07:48 Dealing with being a very public face and the pressures that come with it
14:55 Planning for the future of public health in Canada and the next "x" factor
21:18 Addressing gaps and needs in healthcare communication
28:36 Mapping synergy betwen frontline healthcare providers and public health in Canada
31:03 At the intersection of climate change and public health planning
35:09 What does Dr. Tam have to say to the next generation of leaders on the front line and potentially leaders in public
health?
--------
๐๏ธ ABOUT DR.THERESA TAM
Dr. Theresa Tam was named Canada's Chief Public Health Officer on June 26, 2017. She is a paediatric infectious disease specialist with expertise in immunization, emergency preparedness and global health security.
Dr. Tam obtained her medical degree from the University of Nottingham in the U.K. She completed her paediatric residency at the University of Alberta and her fellowship in paediatric infectious diseases at the University of British Columbia.
She is a Fellow of the Royal College of Physicians and Surgeons of Canada and has over 55 peer-reviewed journal publications in public health. She is also a graduate of the Canadian Field Epidemiology Program.
Dr. Tam has held several senior leadership positions at the Public Health Agency of Canada, including as the Deputy Chief Public Health Officer and the Assistant Deputy Minister for Infectious Disease Prevention and Control. During her 25 years in public health, she provided technical expertise and leadership on new initiatives to improve communicable disease surveillance, enhance immunization programs, strengthen health emergency management and laboratory biosafety and biosecurity. She has played a leadership role in Canada's response to public health emergencies including severe acute respiratory syndrome (SARS), pandemic influenza H1N1 and Ebola.
Dr. Tam has served as an international expert on a number of World Health Organization committees and has participated in multiple international missions related to SARS, pandemic influenza and polio eradication.
-
Your COVID vaccine is getting a makeover (well kind of).
Freshly formulated updated Omicron-specific COVID-19 vaccines are now available.
These new bivalent booster shots rolling out across Canada are specifically tailored to match currently circulating COVID omicron variants and are thought to provide enhanced protection against newer versions of SARS-CoV-2 than our earlier shots. Uptake of booster vaccines has not been anywhere near as high as the initial vaccines.
โถ๏ธ๐ง ๐๏ธ ๐๐ ๐ฌ๐ข๐ญ ๐๐จ๐ฐ๐ง ๐ฐ๐ข๐ญ๐ก ๐ฅ๐๐๐๐ข๐ง๐ ๐๐ฑ๐ฉ๐๐ซt, ๐๐ซ.๐๐๐ข๐ง ๐๐ก๐๐ ๐ฅ๐ who breaks down all you need to know about (in less than 36 minutes):
โ๏ธโ๏ธHow do you approach and recommend the updated bivalent COVID-19 booster to eligible patients
โ๏ธโ๏ธHow should you be framing the efficacy conversation in relation to this bivalent booster-antibody data vs clinical effectiveness
โ๏ธโ๏ธStrategies to increase booster uptake in clinical practice
โ๏ธโ๏ธKey practicalities of the vaccine and how this would fit into your daily practice?
โ๏ธโ๏ธAre breakthrough infections less likely with this updated bivalent booster?
โ๏ธโ๏ธWill this booster still work if the virus mutates again and thereโs a new variant?
โ๏ธโ๏ธ What does the healthcare provider need to know from this discussion to communicate with a patient the next day?
Dr. Zain ChaglaDr.Zain Chagla, MD MSc MD, FRCPC is an associate professor at McMaster University, co-medical director of infection control at St. Josephโs Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.
Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.
As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.
-
๐๐๐ญ๐ข๐๐ง๐ญ๐ฌ ๐ฅ๐ข๐ฏ๐ข๐ง๐ ๐ฐ๐ข๐ญ๐ก ๐ฉ๐จ๐ฌ๐ญ-๐๐๐ฎ๐ญ๐ ๐ฌ๐๐ช๐ฎ๐๐ฅ๐๐ ๐จ๐ ๐๐๐๐-๐๐จ๐-๐ ๐ข๐ง๐๐๐๐ญ๐ข๐จ๐ง (๐๐๐๐), ๐๐๐ ๐ฅ๐จ๐ง๐ ๐๐๐๐๐, ๐ฅ๐ข๐ฏ๐ ๐ฐ๐ข๐ญ๐ก ๐ ๐ฐ๐ข๐๐ ๐๐ซ๐ซ๐๐ฒ ๐จ๐ ๐ฌ๐ฒ๐ฆ๐ฉ๐ญ๐จ๐ฆ๐ฌ, ๐ซ๐๐ง๐ ๐ข๐ง๐ ๐๐ซ๐จ๐ฆ ๐ฆ๐ข๐ฅ๐ ๐ญ๐จ ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ๐ฒ ๐๐๐๐ข๐ฅ๐ข๐ญ๐๐ญ๐ข๐ง๐ .
๐๏ธ๐๏ธ๐๏ธ ๐๐ ๐ฌ๐ข๐ญ ๐๐จ๐ฐ๐ง ๐ฐ๐ข๐ญ๐ก ๐ ๐ฅ๐๐๐๐ข๐ง๐ ๐๐ฑ๐ฉ๐๐ซ๐ญ๐ฌ, ๐๐ซ.๐๐ง๐ ๐๐ฅ๐ ๐๐ก๐๐ฎ๐ง๐ ๐๐ง๐ ๐๐ซ.๐๐๐ข๐ง ๐๐ก๐๐ ๐ฅ๐, ๐ญ๐จ ๐ฌ๐๐๐ค ๐ฌ๐จ๐ฆ๐ ๐๐ฅ๐๐ซ๐ข๐ญ๐ฒ ๐๐๐จ๐ฎ๐ญ ๐ฅ๐จ๐ง๐ ๐๐๐๐๐โ๐ฌ ๐๐๐๐๐๐ญ๐ฌ, ๐ฉ๐จ๐ญ๐๐ง๐ญ๐ข๐๐ฅ ๐ญ๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ๐ฌ, ๐ฌ๐๐ซ๐๐๐ง๐ข๐ง๐ , ๐๐ง๐ ๐ก๐จ๐ฐ ๐ญ๐ก๐ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐ฆ๐ข๐ ๐ก๐ญ ๐ข๐ฆ๐ฉ๐๐๐ญ ๐๐๐ง๐๐๐โ๐ฌ ๐ก๐๐๐ฅ๐ญ๐ก ๐๐๐ซ๐ ๐ฌ๐ฒ๐ฌ๐ญ๐๐ฆ ๐ข๐ง ๐ญ๐ก๐ ๐๐ฎ๐ญ๐ฎ๐ซ๐.โถ๏ธ๐ง ๐๏ธ Dr.Angela M. Cheung and Dr.Zain Chagla breakdown what you need to know about:
โ๏ธโ๏ธโ๏ธ New ๐ง๐๐จ๐๐๐ง๐๐ exploring how recent you've had your last dose of #๐พ๐๐๐๐ฟ-19 ๐ซ๐๐๐๐๐ฃ๐๐ฉ๐๐ค๐ฃ and the link ๐ฌ๐๐ฉ๐ ๐ก๐ค๐ฃ๐ #๐พ๐๐๐๐ฟ ๐จ๐ฎ๐ข๐ฅ๐ฉ๐ค๐ข ๐ข๐๐ฉ๐๐๐๐ฉ๐๐ค๐ฃ.
โ๏ธโ๏ธโ๏ธC๐ช๐ง๐ง๐๐ฃ๐ฉ ๐๐ซ๐๐๐๐ฃ๐๐ ๐๐ฃ๐ ๐ช๐ฃ๐๐๐ง๐จ๐ฉ๐๐ฃ๐๐๐ฃ๐ ๐ค๐ ๐พ๐๐๐๐ฟ ๐ง๐๐๐ฃ๐๐๐๐ฉ๐๐ค๐ฃ ๐๐ฃ๐ ๐ฉ๐๐ ๐ง๐๐จ๐ ๐ค๐ ๐๐๐ซ๐๐ก๐ค๐ฅ๐๐ฃ๐ ๐ก๐ค๐ฃ๐-๐พ๐๐๐๐ฟ
โ๏ธโ๏ธโ๏ธ ๐๐๐ก๐ฅ๐๐ฃ๐ ๐ฎ๐ค๐ช๐ง ๐ฅ๐๐ฉ๐๐๐ฃ๐ฉ๐จ ๐ช๐ฃ๐๐๐ง๐จ๐ฉ๐๐ฃ๐ ๐ฉ๐๐ ๐ง๐๐จ๐ ๐ค๐ ๐๐๐ซ๐๐ก๐ค๐ฅ๐๐ฃ๐ ๐ก๐ค๐ฃ๐ ๐พ๐๐๐๐ฟ ๐จ๐ฎ๐ข๐ฅ๐ฉ๐ค๐ข๐จ ๐๐ฃ ๐๐๐ช๐ก๐ฉ๐จ ๐ฌ๐๐ฉ๐ ๐๐ผ๐๐-๐พ๐ค๐-2 ๐๐ฃ๐๐๐๐ฉ๐๐ค๐ฃ ๐๐๐๐ค๐ง๐ ๐๐ฃ๐ ๐๐๐ฉ๐๐ง ๐ซ๐๐๐๐๐ฃ๐๐ฉ๐๐ค๐ฃ.
Dr. Angela CheungDr. Angela Cheung is the KY and Betty Ho Chair of Integrative Medicine at the University of Toronto and is a professor of medicine and internal medicine specialist, as well as a senior scientist at the University Health Network in Toronto. Dr.Cheung holds a Tier 1 Canada Research Chair and She obtained her M.D. degree from Johns Hopkins University School of Medicine, and her Ph.D. degree from Harvard University.
Dr.Cheung is the co-lead of CANCOV (Canadian COVID-19 Prospective Cohort Study) as well as RECLAIM (REcovering from COVIDโ19 Lingering symptoms Adaptive Integrative Medicine) trial, a Canada-wide, open-label, pragmatic, adaptive randomized clinical trial platform to assess the effectiveness of various interventions in patients with lingering symptoms of COVIDโ19.
Dr. Zain ChaglaDr.Zain Chagla, MD MSc MD, FRCPC is an associate professor at McMaster University, co-medical director of infection control at St. Josephโs Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.
Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.
As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.
Resources to further explore:
The Canadian COVID-19 Prospective Cohort Study (CANCOV) RECLAIM (REcovering from COVIDโ19 Lingering symptoms Adaptive Integrative Medicine) trialLancet: Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 -
๐๐๐ญ๐ข๐๐ง๐ญ๐ฌ ๐ฅ๐ข๐ฏ๐ข๐ง๐ ๐ฐ๐ข๐ญ๐ก ๐ฉ๐จ๐ฌ๐ญ-๐๐๐ฎ๐ญ๐ ๐ฌ๐๐ช๐ฎ๐๐ฅ๐๐ ๐จ๐ ๐๐๐๐-๐๐จ๐-๐ ๐ข๐ง๐๐๐๐ญ๐ข๐จ๐ง (๐๐๐๐), ๐๐๐ ๐ฅ๐จ๐ง๐ ๐๐๐๐๐, ๐ฅ๐ข๐ฏ๐ ๐ฐ๐ข๐ญ๐ก ๐ ๐ฐ๐ข๐๐ ๐๐ซ๐ซ๐๐ฒ ๐จ๐ ๐ฌ๐ฒ๐ฆ๐ฉ๐ญ๐จ๐ฆ๐ฌ, ๐ซ๐๐ง๐ ๐ข๐ง๐ ๐๐ซ๐จ๐ฆ ๐ฆ๐ข๐ฅ๐ ๐ญ๐จ ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ๐ฒ ๐๐๐๐ข๐ฅ๐ข๐ญ๐๐ญ๐ข๐ง๐ .
๐๏ธ๐๏ธ๐๏ธ ๐๐ ๐ฌ๐ข๐ญ ๐๐จ๐ฐ๐ง ๐ฐ๐ข๐ญ๐ก ๐ ๐ฅ๐๐๐๐ข๐ง๐ ๐๐ฑ๐ฉ๐๐ซ๐ญ๐ฌ, ๐๐ซ.๐๐ง๐ ๐๐ฅ๐ ๐๐ก๐๐ฎ๐ง๐ ๐๐ง๐ ๐๐ซ.๐๐๐ข๐ง ๐๐ก๐๐ ๐ฅ๐, ๐ญ๐จ ๐ฌ๐๐๐ค ๐ฌ๐จ๐ฆ๐ ๐๐ฅ๐๐ซ๐ข๐ญ๐ฒ ๐๐๐จ๐ฎ๐ญ ๐ฅ๐จ๐ง๐ ๐๐๐๐๐โ๐ฌ ๐๐๐๐๐๐ญ๐ฌ, ๐ฉ๐จ๐ญ๐๐ง๐ญ๐ข๐๐ฅ ๐ญ๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ๐ฌ, ๐ฌ๐๐ซ๐๐๐ง๐ข๐ง๐ , ๐๐ง๐ ๐ก๐จ๐ฐ ๐ญ๐ก๐ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐ฆ๐ข๐ ๐ก๐ญ ๐ข๐ฆ๐ฉ๐๐๐ญ ๐๐๐ง๐๐๐โ๐ฌ ๐ก๐๐๐ฅ๐ญ๐ก ๐๐๐ซ๐ ๐ฌ๐ฒ๐ฌ๐ญ๐๐ฆ ๐ข๐ง ๐ญ๐ก๐ ๐๐ฎ๐ญ๐ฎ๐ซ๐.๐ก ๐ก ๐ก ๐๐๐๐ฉ ๐๐๐ฃ ๐๐ ๐๐ค๐ฃ๐ ๐ฉ๐ค ๐๐๐ก๐ฅ ๐ฎ๐ค๐ช๐ง ๐ฅ๐๐ฉ๐๐๐ฃ๐ฉ๐จ ๐ฌ๐๐ฉ๐ ๐ก๐ค๐ฃ๐ ๐พ๐๐๐๐ฟ?
๐ก ๐ก ๐ฟ๐ค๐๐จ ๐๐๐๐ฃ๐ ๐๐ช๐ก๐ก๐ฎ ๐ซ๐๐๐๐๐ฃ๐๐ฉ๐๐ ๐ค๐ง ๐๐ค๐ค๐จ๐ฉ๐๐ ๐ข๐๐ฉ๐๐๐๐ฉ๐ ๐ฉ๐๐ ๐ง๐๐จ๐ ๐ค๐ ๐๐ค๐ฃ๐ฉ๐ง๐๐๐ฉ๐๐ฃ๐ ๐๐๐๐ ๐พ๐๐๐๐ฟ ๐ค๐ง ๐ข๐๐ฉ๐๐๐๐ฉ๐ ๐ฉ๐๐ ๐จ๐๐ฆ๐ช๐๐ก๐๐ ๐ค๐ ๐๐ฉ? ๐ฟ๐ค๐๐จ ๐ฉ๐๐ ๐ง๐๐๐๐ฃ๐๐ฎ ๐ค๐ ๐ฎ๐ค๐ช๐ง ๐พ๐๐๐๐ฟ ๐๐ค๐ค๐จ๐ฉ๐๐ง ๐ค๐ง ๐ซ๐๐๐๐๐ฃ๐๐ฉ๐๐ค๐ฃ ๐๐ก๐จ๐ค ๐ฅ๐ก๐๐ฎ ๐ ๐ง๐ค๐ก๐?
๐ก ๐๐ค๐ฌ ๐จ๐๐ค๐ช๐ก๐ ๐ฌ๐ ๐๐ ๐ฉ๐๐๐ฃ๐ ๐๐ฃ๐ ๐๐๐ค๐ช๐ฉ ๐๐ค๐ข๐ข๐ช๐ฃ๐๐๐๐ฉ๐๐ฃ๐ ๐ฉ๐๐ ๐๐ค๐ฃ๐๐๐ฅ๐ฉ ๐ค๐ ๐ง๐๐จ๐ , ๐๐ฃ๐ ๐๐ง๐๐ข๐๐ฃ๐ ๐ง๐๐จ๐ ๐ฉ๐ค ๐ค๐ช๐ง ๐ฅ๐๐ฉ๐๐๐ฃ๐ฉ๐จ ๐๐ฃ ๐ฉ๐๐ ๐๐ค๐ฃ๐ฉ๐๐ญ๐ฉ ๐ค๐ ๐ก๐ค๐ฃ๐ ๐พ๐๐๐๐ฟ?
Dr. Angela CheungDr. Angela Cheung is the KY and Betty Ho Chair of Integrative Medicine at the University of Toronto and is a professor of medicine and internal medicine specialist, as well as a senior scientist at the University Health Network in Toronto. Dr.Cheung holds a Tier 1 Canada Research Chair and She obtained her M.D. degree from Johns Hopkins University School of Medicine, and her Ph.D. degree from Harvard University.
Dr.Cheung is the co-lead of CANCOV (Canadian COVID-19 Prospective Cohort Study) as well as RECLAIM (REcovering from COVIDโ19 Lingering symptoms Adaptive Integrative Medicine) trial, a Canada-wide, open-label, pragmatic, adaptive randomized clinical trial platform to assess the effectiveness of various interventions in patients with lingering symptoms of COVIDโ19.
Dr. Zain ChaglaDr.Zain Chagla, MD MSc MD, FRCPC is an associate professor at McMaster University, co-medical director of infection control at St. Josephโs Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.
Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.
As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.
Resources to further explore:
The Canadian COVID-19 Prospective Cohort Study (CANCOV) RECLAIM (REcovering from COVIDโ19 Lingering symptoms Adaptive Integrative Medicine) trialLancet: Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 -
โถ๏ธโถ๏ธ Les patients ร haut risque voient aujourd'hui une combinaison de variantes COVID plus transmissibles et de vaccins dont l'efficacitรฉ peut diminuer.
Mais lorsque nous pensons aux patients ร haut risque et aux patients cliniquement vulnรฉrables, nous pensons souvent ร la population de patients IC. Que diriez-vous si vous รชtes obรจse ou souffrez de diabรจte, d'insuffisance cardiaque, d'hypercholestรฉrolรฉmie, d'hypertension ? Qu'en est-il de ceux qui ont des handicaps cognitifs ou physiques spรฉcifiques ? Qu'est-ce qu'un risque รฉlevรฉ au-delร de la population de patients immunodรฉprimรฉs ?
Nous sommes rejoints par deux experts en maladies infectieuses qui dispensent une masterclass en temps rรฉel sur l'รฉvaluation du risque de COVID chez vos patients et connectent les donnรฉes รฉmergentes autour des 1er et 2e rappels du vaccin COVID-19.
๐ฐ ๐บ Les fameuses questions "Demandez ร l'expert" de cet รฉpisode explorent des facteurs de risque spรฉcifiques au-delร de l'รขge et comment traduire et encadrer efficacement la conversation de rappel en premiรจre ligne avec votre patient. Comment dรฉpister et communiquer en premiรจre ligne ? Et comment regardons-nous les conseils du NACI sur les rappels par rapport aux recommandations du JCVI pour l'automne ?OBJECTIFS D'APPRENTISSAGE DE L'รPISODE :
o Explorer la comprรฉhension et la dรฉfinition actuelles des populations de patients ร haut risque et comment stratifier le risque dans le contexte de la progression vers une maladie COVID-19 sรฉvรจre en fonction des comorbiditรฉs
o Dรฉmontrer comment les prestataires de soins de santรฉ de premiรจre ligne peuvent dรฉpister efficacement les patients prรฉsentant des comorbiditรฉs pour des doses de rappel COVID-19
o Dรฉcrire comment encadrer efficacement la communication des vaccins de rappel COVID-19 dans le contexte des questions cliniques rรฉelles des patients
-
Dr. Zain Chagla
Dr.Zain Chagla, MD MSc MD, FRCPC is an associate professor at McMaster University, co-medical director of infection control at St. Josephโs Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.
Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.
As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control.
Dr. Srinivas MurthyDr. Srinivas Murthy MD MASc FRCPC is the Health Research Foundation of Innovative Medicines Canada Chair in Pandemic Preparedness Research, and co-chair of the World Health Organizationโs (WHO) clinical research committee on COVID-19. He is an associate professor in the Faculty of Medicine at University of British Columbia, as well as a critical care and infectious diseases physician at B.C. Childrenโs Hospital in Vancouver. Murthyโs research focuses on infectious disease, clinical practice and clinical trials, and global health. He has also worked on the frontlines for a number of infectious disease outbreaks, including work on Ebola in Liberia, West Africa.
NEJM: Protection by a Fourth Dose of BNT162b2 against Omicron in Israel
https://www.nejm.org/doi/full/10.1056/NEJMoa2201570?query=recirc_mostViewed_railB_articleJCVI interim statement on COVID-19 autumn 2022 vaccination programme
https://www.gov.uk/government/publications/jcvi-interim-statement-on-covid-19-autumn-2022-vaccination-programme
-
โ๏ธ ๐ถ ๐๐จ๐ฎ ๐ ๐๐ญ ๐ ๐ฉ๐ก๐จ๐ง๐ ๐๐๐ฅ๐ฅ ๐ญ๐จ ๐จ๐ซ๐ ๐๐ง๐ข๐ณ๐ ๐๐ง ๐๐ง๐ญ๐ข๐ซ๐ ๐๐ซ๐จ๐ฏ๐ข๐ง๐๐'๐ฌ ๐ฏ๐๐๐๐ข๐ง๐ ๐๐๐ฆ๐ฉ๐๐ข๐ ๐ง ๐๐ซ๐จ๐ฆ ๐ก๐ข๐ซ๐ข๐ง๐ ๐ฌ๐ญ๐๐๐, ๐ญ๐จ ๐ฌ๐๐๐ฎ๐ซ๐ข๐ง๐ ๐๐ฅ๐ข๐ง๐ข๐๐ฌ, ๐ญ๐จ ๐๐ฏ๐๐ฅ๐ฎ๐๐ญ๐ข๐ง๐ ๐ญ๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐ญ๐ก๐๐ญ ๐ก๐๐ฌ ๐ญ๐จ ๐ฐ๐จ๐ซ๐ค ๐ข๐ง ๐ซ๐๐๐ฅ ๐ญ๐ข๐ฆ๐-๐ฐ๐ข๐ญ๐ก ๐ ๐๐๐ฐ ๐ฐ๐๐๐ค๐ฌ ๐ญ๐จ ๐ฌ๐ฉ๐๐ซ๐ ๐๐ง๐ ๐ง๐จ ๐ซ๐๐๐ฅ ๐ฉ๐ฅ๐๐ฒ๐๐จ๐จ๐ค-๐ฐ๐จ๐ฎ๐ฅ๐ ๐ฒ๐จ๐ฎ ๐๐๐๐๐ฉ๐ญ?
๐ฌ๐๐ ๐ ๐จ ๐๐๐ก๐ข๐ง๐ ๐ญ๐ก๐ ๐ฌ๐๐๐ง๐๐ฌ ๐จ๐ ๐๐'๐ฌ ๐ฅ๐๐ซ๐ ๐๐ฌ๐ญ ๐ฉ๐ฎ๐๐ฅ๐ข๐ #๐ก๐๐๐ฅ๐ญ๐ก ๐๐๐ฆ๐ฉ๐๐ข๐ ๐ง ๐ข๐ง ๐๐ง ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐จ๐ง๐ฏ๐๐ซ๐ฌ๐๐ญ๐ข๐จ๐ง ๐ฐ๐ข๐ญ๐ก ๐๐ซ.๐๐๐ง๐ง๐ฒ ๐๐๐ฅ๐ฅ๐๐ฆ, ๐ฐ๐ก๐จ ๐ซ๐๐๐ฅ๐๐๐ญ๐ฌ ๐จ๐ง ๐ก๐จ๐ฐ ๐ฌ๐๐ซ๐ฏ๐ข๐ง๐ ๐ข๐ง ๐ฉ๐ซ๐๐ฏ๐ข๐จ๐ฎ๐ฌ ๐ฅ๐๐๐๐๐ซ๐ฌ๐ก๐ข๐ฉ ๐ซ๐จ๐ฅ๐๐ฌ ๐ฉ๐ซ๐๐ฉ๐๐ซ๐๐ ๐ก๐๐ซ ๐๐จ๐ซ ๐ฅ๐๐๐๐ข๐ง๐ ๐๐'๐ฌ #๐๐๐๐๐-๐๐ #๐ฏ๐๐๐๐ข๐ง๐ ๐ซ๐จ๐ฅ๐ฅ๐จ๐ฎ๐ญ.
๐ ๐๐จ๐ฎ ๐๐จ๐ง'๐ญ ๐ฐ๐๐ง๐ญ ๐ญ๐จ ๐ฆ๐ข๐ฌ๐ฌ ๐ก๐๐ซ ๐ฆ๐๐ฌ๐ฌ๐๐ ๐ ๐๐จ๐ซ ๐ฒ๐จ๐ฎ๐ง๐ ๐ฅ๐๐๐๐๐ซ๐ฌ ๐ข๐ง #๐ฉ๐ก๐๐ซ๐ฆ๐๐๐ฒ ๐๐ง๐ #๐ก๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐.
DR.PENNY BALLEM
Dr.Ballem is the executive lead for British Columbia's COVID-19 vaccine rollout and immunization efforts and is Chair of the board of Vancouver Coastal Health.She's served in the past as BC's Deputy Minister of Health and City Manager for the City of Vancouver. She's a former board director of the Canadian Institute for Health Information (CIHI) and advises governments across Canada on health policy, health systems, and health human resources.
-
โถ๏ธ ๐ฌ ๐ฌ ๐ช๐ฒ ๐๐ถ๐ ๐ฑ๐ผ๐๐ป ๐๐ถ๐๐ต ๐๐โ๐ ๐๐ต๐ถ๐ฒ๐ณ ๐ ๐ฒ๐ฑ๐ถ๐ฐ๐ฎ๐น ๐๐ฒ๐ฎ๐น๐๐ต ๐ข๐ณ๐ณ๐ถ๐ฐ๐ฒ๐ฟ and findmyvaccine podcast Faculty, ๐๐ฟ.๐๐ผ๐ป๐ป๐ถ๐ฒ ๐๐ฒ๐ป๐ฟ๐, ๐ผ๐ป ๐ฎ ๐ฟ๐ฎ๐ป๐ด๐ฒ of issues in PART 2 of our conversation.
๐ก๐ก๐๏ธ Dr.Henry ๐ฌ๐ก๐๐ซ๐๐ฌ her ๐ฉ๐๐ซ๐ฌ๐จ๐ง๐๐ฅ ๐๐ฑ๐ฉ๐๐ซ๐ข๐๐ง๐๐ ๐ง๐๐ฏ๐ข๐ ๐๐ญ๐ข๐ง๐ an ๐๐ฏ๐๐ซ๐๐ก๐๐ง๐ ๐ข๐ง๐ ๐ฉ๐ฎ๐๐ฅ๐ข๐ ๐ก๐๐๐ฅ๐ญ๐ก ๐ฅ๐๐ง๐๐ฌ๐๐๐ฉ๐ ๐๐ง๐ battling a duelling pandemics- COVID19 and the opioid crisis.
๐กโ๏ธ She also walks ๐๐ ๐๐ต๐ฟ๐ผ๐๐ด๐ต her thoughts for what the future may look like with the COVID-19 pandemic.๐
๐ก ๐ช๐ต๐ฎ๐ ๐ฑ๐ผ๐ฒ๐ ๐ด๐ผ๐ผ๐ฑ ๐ฝ๐๐ฏ๐น๐ถ๐ฐ ๐ต๐ฒ๐ฎ๐น๐๐ต ๐ฑ๐ฒ๐ฐ๐ถ๐๐ถ๐ผ๐ป ๐บ๐ฎ๐ธ๐ถ๐ป๐ด ๐น๐ผ๐ผ๐ธ ๐น๐ถ๐ธ๐ฒ in a pandemic?
PART 1 of the episode: https://findmyvaccine.simplecast.com/episodes/kind-calm-and-safe-leading-in-a-time-of-covid-19
Dr. Bonnie Henry, MD MPH FRCPC, BC Provincial Health OfficerAs BCโs most senior public health official, Dr. Henry is responsible for monitoring the health of all British Columbians and undertaking measures for disease prevention and control and health protection. Most recently, Dr. Henry has led the provinceโs response on the COVID-19 pandemic and drug overdose emergency.
Dr. Henryโs experience in public health, preventative medicine and global pandemics has extended throughout her career. Prior to her current role, Dr. Henry was the deputy provincial health officer for three years. She also served as the interim provincial executive medical director of the BC Centre for Disease Control (BCCDC) from December 2013 until August 2014.
She was the medical director of Communicable Disease Prevention and Control and Public Health Emergency Management with the BCCDC and medical director for the provincial emerging and vector-borne diseases program, as well as a provincial program for surveillance and control of healthcare associated infections from 2005 to 2014.
Dr. Henry joined Toronto Public Health in 2001 as Associate Medical Officer of Health, where she was responsible for the Emergency Services Unit and the Communicable Disease Liaison Unit. In 2003, she was the operational lead in the response to the SARS outbreak in Toronto. She was a member of the executive team of the Ontario SARS Scientific Advisory Committee.
Dr. Henry is a specialist in public health and preventive medicine and is board certified in preventive medicine in the U.S. She graduated from Dalhousie Medical School and completed a Masters in Public Health in San Diego, residency training in preventive medicine at University of California, San Diego and in community medicine at University of Toronto.
She has worked internationally including with the WHO/UNICEF polio eradication program in Pakistan and with the World Health Organization to control the Ebola outbreak in Uganda.
Dr. Henry is an associate professor at the University of British Columbia, Faculty of Medicine. She is the past chair of Immunize Canada and a member of the Canadian National Advisory Committee on Immunization and the National Infection Control Guidelines Steering Committee. She chaired the Canadian Public Health Measures Task Group and was a member of the Infection Control Expert Group and the Canadian Pandemic Coordinating Committee responding to the 2009 H1N1 influenza pandemic.
She has been involved with planning, surveillance and response to mass gatherings in Canada and internationally, including with the Vancouver 2010 Olympic and Paralympic Winter Games. She is also the author of โSoap and Water and Common Senseโ a guide to staying healthy in a microbe filled world.
New York Times: The Top Doctor Who Aced the Coronavirus Test -
โถ๏ธ ๐ฌ ๐ฌ ๐ช๐ฒ ๐๐ถ๐ ๐ฑ๐ผ๐๐ป ๐๐ถ๐๐ต ๐๐โ๐ ๐๐ต๐ถ๐ฒ๐ณ ๐ ๐ฒ๐ฑ๐ถ๐ฐ๐ฎ๐น ๐๐ฒ๐ฎ๐น๐๐ต ๐ข๐ณ๐ณ๐ถ๐ฐ๐ฒ๐ฟ and findmyvaccine podcast Faculty, ๐๐ฟ.๐๐ผ๐ป๐ป๐ถ๐ฒ ๐๐ฒ๐ป๐ฟ๐, ๐ผ๐ป ๐ฎ ๐ฟ๐ฎ๐ป๐ด๐ฒ of issues.
๐ก๐ก๐๏ธ Dr.Henry ๐ฌ๐ก๐๐ซ๐๐ฌ her ๐ฉ๐๐ซ๐ฌ๐จ๐ง๐๐ฅ ๐๐ฑ๐ฉ๐๐ซ๐ข๐๐ง๐๐ ๐ง๐๐ฏ๐ข๐ ๐๐ญ๐ข๐ง๐ an ๐๐ฏ๐๐ซ๐๐ก๐๐ง๐ ๐ข๐ง๐ ๐ฉ๐ฎ๐๐ฅ๐ข๐ ๐ก๐๐๐ฅ๐ญ๐ก ๐ฅ๐๐ง๐๐ฌ๐๐๐ฉ๐ ๐๐ง๐ ๐ฅ๐๐ฌ๐ฌ๐จ๐ง๐ฌ ๐จ๐ง ๐ฅ๐๐๐๐ข๐ง๐ ๐ข๐ง ๐ญ๐ฎ๐ฆ๐ฎ๐ฅ๐ญ๐ฎ๐จ๐ฎ๐ฌ ๐ญ๐ข๐ฆ๐๐ฌ.
She also walks ๐๐ ๐๐ต๐ฟ๐ผ๐๐ด๐ต ๐ต๐ผ๐ ๐๐ต๐ฒ ๐บ๐ฎ๐ธ๐ฒ๐ ๐๐ผ๐บ๐ฒ ๐ผ๐ณ ๐ต๐ฒ๐ฟ ๐ธ๐ฒ๐ ๐ฑ๐ฒ๐ฐ๐ถ๐๐ถ๐ผ๐ป๐.๐
โ๏ธ D๐ฒ๐ฐ๐ถ๐๐ถ๐ผ๐ป๐ ๐๐ถ๐น๐น ๐ฎ๐น๐๐ฎ๐๐ ๐ต๐ฎ๐๐ฒ ๐ฎ ๐ฐ๐ผ๐บ๐ฝ๐ผ๐ป๐ฒ๐ป๐ ๐ผ๐ณ ๐ฎ๐๐๐ผ๐ฐ๐ถ๐ฎ๐๐ฒ๐ฑ ๐๐ป๐ฐ๐ฒ๐ฟ๐๐ฎ๐ถ๐ป๐๐.
๐ก ๐ช๐ต๐ฎ๐ ๐ฑ๐ผ๐ฒ๐ ๐ด๐ผ๐ผ๐ฑ ๐ฝ๐๐ฏ๐น๐ถ๐ฐ ๐ต๐ฒ๐ฎ๐น๐๐ต ๐ฑ๐ฒ๐ฐ๐ถ๐๐ถ๐ผ๐ป ๐บ๐ฎ๐ธ๐ถ๐ป๐ด ๐น๐ผ๐ผ๐ธ ๐น๐ถ๐ธ๐ฒ in a pandemic?
โ๏ธ ๐๐ผ๐ ๐ฑ๐ผ ๐๐ผ๐ ๐ฐ๐ฟ๐ฒ๐ฎ๐๐ฒ ๐ฎ ๐๐ฒ๐ป๐๐ฒ ๐ผ๐ณ ๐ฐ๐ฒ๐ฟ๐๐ฎ๐ถ๐ป๐๐ ๐ฎ๐บ๐ถ๐ฑ๐๐ ๐ฎ ๐ฝ๐ฎ๐ป๐ฑ๐ฒ๐บ๐ถ๐ฐ ๐ฐ๐ต๐ฎ๐ฟ๐ฎ๐ฐ๐๐ฒ๐ฟ๐ถ๐๐ฒ๐ฑ ๐ผ๐ป๐น๐ ๐ฏ๐ ๐๐ป๐ฐ๐ฒ๐ฟ๐๐ฎ๐ถ๐ป๐๐?
Dr. Bonnie Henry, MD MPH FRCPC, BC Provincial Health Officer
As BCโs most senior public health official, Dr. Henry is responsible for monitoring the health of all British Columbians and undertaking measures for disease prevention and control and health protection. Most recently, Dr. Henry has led the provinceโs response on the COVID-19 pandemic and drug overdose emergency.
Dr. Henryโs experience in public health, preventative medicine and global pandemics has extended throughout her career. Prior to her current role, Dr. Henry was the deputy provincial health officer for three years. She also served as the interim provincial executive medical director of the BC Centre for Disease Control (BCCDC) from December 2013 until August 2014.
She was the medical director of Communicable Disease Prevention and Control and Public Health Emergency Management with the BCCDC and medical director for the provincial emerging and vector-borne diseases program, as well as a provincial program for surveillance and control of healthcare associated infections from 2005 to 2014.
Dr. Henry joined Toronto Public Health in 2001 as Associate Medical Officer of Health, where she was responsible for the Emergency Services Unit and the Communicable Disease Liaison Unit. In 2003, she was the operational lead in the response to the SARS outbreak in Toronto. She was a member of the executive team of the Ontario SARS Scientific Advisory Committee.
Dr. Henry is a specialist in public health and preventive medicine and is board certified in preventive medicine in the U.S. She graduated from Dalhousie Medical School and completed a Masters in Public Health in San Diego, residency training in preventive medicine at University of California, San Diego and in community medicine at University of Toronto.
She has worked internationally including with the WHO/UNICEF polio eradication program in Pakistan and with the World Health Organization to control the Ebola outbreak in Uganda.
Dr. Henry is an associate professor at the University of British Columbia, Faculty of Medicine. She is the past chair of Immunize Canada and a member of the Canadian National Advisory Committee on Immunization and the National Infection Control Guidelines Steering Committee. She chaired the Canadian Public Health Measures Task Group and was a member of the Infection Control Expert Group and the Canadian Pandemic Coordinating Committee responding to the 2009 H1N1 influenza pandemic.
She has been involved with planning, surveillance and response to mass gatherings in Canada and internationally, including with the Vancouver 2010 Olympic and Paralympic Winter Games. She is also the author of โSoap and Water and Common Senseโ a guide to staying healthy in a microbe filled world.
New York Times: The Top Doctor Who Aced the Coronavirus Test -
Dr. Karl Weiss, M.D., M. Sc., FRCPC
Le Dr Karl Weiss est microbiologiste et spรฉcialiste en maladies infectieuses ร lโHรดpital gรฉnรฉral juif de Montrรฉal ainsi que professeur ร la Facultรฉ de mรฉdecine de lโUniversitรฉ McGill. Il est chef de la Division des maladies infectieuses de lโHรดpital gรฉnรฉral juif de Montrรฉal, qui est lโhรดpital ayant le plus important volume clinique en maladies infectieuses au Canada.Il a ลuvrรฉ comme microbiologiste-infectiologue ร lโHรดpital Maisonneuve-Rosemont de 1994 ร 2016, et y a occupรฉ de trรจs nombreuses fonctions, dont celle de chef de dรฉpartement durant plusieurs annรฉes. Il est รฉgalement professeur titulaire de clinique ร la Facultรฉ de mรฉdecine de lโUniversitรฉ de Montrรฉal et a รฉtรฉ directeur de la recherche pharmacologique ร lโHรดpital Maisonneuve-Rosemont de 2001 ร 2013. Il a รฉgalement รฉtรฉ coprรฉsident de la Table en prรฉvention et contrรดle des infections de lโรle de Montrรฉal.
Aprรจs avoir reรงu son doctorat en mรฉdecine de lโUniversitรฉ de Montrรฉal en 1989, le Dr Weiss a poursuivi ses รฉtudes en mรฉdecine interne ร lโUniversitรฉ de Montrรฉal et ร lโUniversitรฉ McGill, puis a terminรฉ sa formation en maladies infectieuses et en microbiologie ร lโUniversitรฉ de Montrรฉal. Il a รฉgalement effectuรฉ des รฉtudes postdoctorales et obtenu une maรฎtrise en รฉpidรฉmiologie clinique. Il a รฉtudiรฉ de nouvelles mรฉthodes de dรฉtection et de nouveaux antibiotiques dans le traitement des infections ร Helicobacter pylori.
Au cours de sa carriรจre, le Dr Weiss a participรฉ comme invitรฉ ร plus de 500 confรฉrences au Canada et ร lโinternational. Il a prรฉsentรฉ ou publiรฉ plus de 400 rรฉsumรฉs et articles dans des journaux prestigieux comme The New England Journal of Medicine, The Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Canadian Journal of Infectious Diseases, American Journal of Epidemiology, Clinical Infectious Diseases and Infection Control and Hospital Epidemiology. Ses recherches se concentrent principalement sur les infections des voies respiratoires, les antibiotiques et la rรฉsistance antimicrobienne. Lโรฉquipe de recherche du Dr Weiss a souvent รฉtรฉ lโune des premiรจres au Canada ร travailler avec les nouveaux antibiotiques en dรฉveloppement.
Le Dr Weiss est aussi le prรฉsident de lโAssociation des mรฉdecins microbiologistes-infectiologues du Quรฉbec (AMMIQ) et il a prรฉsidรฉ de nombreux comitรฉs quรฉbรฉcois et canadiens dans le domaine des maladies infectieuses. En 2005, il a รฉtรฉ le prรฉsident du Congrรจs mondial sur la pneumonie, qui sโest tenu ร Montrรฉal. Par ailleurs, il a prรฉsidรฉ le jury dโexamen en microbiologie mรฉdicale du Collรจge royal des mรฉdecins et chirurgiens du Canada entre 2002 et 2005. Il a longtemps siรฉgรฉ ร lโexรฉcutif de lโAssociation canadienne de microbiologie mรฉdicale et dโinfectiologie (AMMI Canada) et a reprรฉsentรฉ cet organisme ร plusieurs comitรฉs.
Il a reรงu le prix Distinction de la Sociรฉtรฉ canadienne des maladies infectieuses en 2005 et le prix Mรฉdecin de cลur et dโaction de lโAssociation des mรฉdecins de langue franรงaise du Canada en 2008. Le Dr Weiss est trรจs souvent sollicitรฉ par les mรฉdias pour discuter de problรจmes liรฉs aux maladies infectieuses.
-
"๐โ๐๐ฒ ๐ต๐ฎ๐ฑ ๐๐๐ผ ๐๐ข๐ฉ๐๐-๐ญ๐ต ๐ฑ๐ผ๐๐ฒ๐ ๐ฎ๐ป๐ฑ ๐ฑ๐ผ๐ปโ๐ ๐ณ๐ฒ๐ฒ๐น ๐ฎ๐ป๐ ๐๐ฟ๐ด๐ฒ๐ป๐ฐ๐ ๐๐ผ ๐ด๐ฒ๐ ๐ฎ ๐๐ต๐ถ๐ฟ๐ฑ."
๐ช๐ฒ ๐๐ถ๐ ๐ฑ๐ผ๐๐ป ๐๐ถ๐๐ต ๐ฎ ๐ถ๐ป๐ณ๐ฒ๐ฐ๐๐ถ๐ผ๐๐ ๐ฑ๐ถ๐๐ฒ๐ฎ๐๐ฒ ๐ฒ๐ ๐ฝ๐ฒ๐ฟ๐๐ ๐ฎ๐ป๐ฑ ๐ฐ๐ต๐ฎ๐ ๐ฎ๐ฏ๐ผ๐๐ ๐๐ข๐ฉ๐๐-๐ญ๐ต ๐๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ ๐ฏ๐ผ๐ผ๐๐๐ฒ๐ฟ๐. ๐๐ฟ.๐ฆ๐ฟ๐ถ๐ป๐ถ๐๐ฎ๐ ๐ ๐๐ฟ๐๐ต๐ ๐ฎ๐ป๐ฑ ๐๐ฟ.๐๐น๐ผ๐ป ๐ฉ๐ฎ๐ถ๐๐บ๐ฎ๐ป ๐ฒ๐ ๐ฝ๐น๐ผ๐ฟ๐ฒ ๐ต๐ผ๐ ๐๐ผ ๐ฒ๐ณ๐ณ๐ฒ๐ฐ๐๐ถ๐๐ฒ๐น๐ ๐ณ๐ฟ๐ฎ๐บ๐ฒ ๐๐ต๐ฒ ๐ฏ๐ผ๐ผ๐๐๐ฒ๐ฟ ๐ฐ๐ผ๐ป๐๐ฒ๐ฟ๐๐ฎ๐๐ถ๐ผ๐ป ๐๐ถ๐๐ต ๐ฝ๐ฎ๐๐ถ๐ฒ๐ป๐๐. ๐ช๐ถ๐๐ต ๐๐ฎ๐ป๐ถ๐ป๐ด ๐ฑ๐ฒ๐บ๐ฎ๐ป๐ฑ ๐๐ต๐ผ๐๐น๐ฑ ๐๐ฒ ๐ฏ๐ฒ ๐๐ต๐ถ๐ป๐ธ๐ถ๐ป๐ด ๐ผ๐ณ ๐ฎ๐ฑ๐ฑ๐ถ๐ป๐ด ๐ฎ ๐ฏ๐ผ๐ผ๐๐๐ฒ๐ฟ ๐ฟ๐ฒ๐พ๐๐ถ๐ฟ๐ฒ๐บ๐ฒ๐ป๐ ๐๐ผ ๐๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ ๐ฐ๐ฒ๐ฟ๐๐ถ๐ณ๐ถ๐ฐ๐ฎ๐๐ฒ๐?
๐๐ฎ๐ ๐บ๐ฒ๐๐๐ฎ๐ด๐ถ๐ป๐ด ๐ณ๐ฟ๐ผ๐บ ๐ฝ๐๐ฏ๐น๐ถ๐ฐ ๐ต๐ฒ๐ฎ๐น๐๐ต ๐น๐ฒ๐ฎ๐ฑ๐ฒ๐ฟ๐ ๐ฎ๐ป๐ฑ ๐ณ๐ฟ๐ผ๐ป๐๐น๐ถ๐ป๐ฒ ๐๐๐ฃ๐ ๐ฎ๐ฟ๐ผ๐๐ป๐ฑ ๐๐ต๐ฒ ๐ถ๐บ๐ฝ๐ผ๐ฟ๐๐ฎ๐ป๐ฐ๐ฒ ๐ผ๐ณ ๐๐ต๐ฒ ๐ฏ๐ผ๐ผ๐๐๐ฒ๐ฟ ๐ฑ๐ผ๐๐ฒ ๐ฏ๐ฒ๐ฒ๐ป ๐ฐ๐น๐ฒ๐ฎ๐ฟ ๐ฒ๐ป๐ผ๐๐ด๐ต?
๐ฆ๐ต๐ผ๐๐น๐ฑ ๐๐ฒ ๐ฒ๐๐ฒ๐ป ๐ฐ๐ฎ๐น๐น ๐ถ๐ ๐ฎ ๐ฏ๐ผ๐ผ๐๐๐ฒ๐ฟ ๐ฑ๐ผ๐๐ฒ? ๐๐ ๐ถ๐ ๐ฏ๐ฒ๐๐๐ฒ๐ฟ ๐ฑ๐ฒ๐๐ฐ๐ฟ๐ถ๐ฏ๐ฒ๐ฑ ๐ฎ๐ ๐ฏ๐ฒ๐ถ๐ป๐ด ๐ณ๐๐น๐น๐ ๐๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฎ๐๐ฒ๐ฑ? ๐๐๐น๐น๐ ๐๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฎ๐๐ฒ๐ฑ ๐๐ถ๐๐ต ๐ฎ๐ป ๐ฎ๐ฑ๐ฑ๐ถ๐๐ถ๐ผ๐ป๐ฎ๐น ๐ฑ๐ผ๐๐ฒ? ๐ง๐ฟ๐ถ๐ฝ๐น๐ฒ ๐๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฎ๐๐ฒ๐ฑ?
๐ง๐ต๐ฒ ๐ฝ๐ฎ๐ป๐ฒ๐น ๐ฎ๐น๐๐ผ ๐ฎ๐ป๐๐๐ฒ๐ฟ๐ ๐ฎ๐น๐น ๐๐ผ๐๐ฟ ๐ฏ๐๐ฟ๐ป๐ถ๐ป๐ด ๐๐ข๐ฉ๐๐ ๐ฏ๐ผ๐ผ๐๐๐ฒ๐ฟ ๐พ๐๐ฒ๐๐๐ถ๐ผ๐ป๐ ๐ณ๐ฟ๐ผ๐บ ๐๐ต๐ฒ ๐ณ๐ฟ๐ผ๐ป๐๐น๐ถ๐ป๐ฒ๐.
Dr. Srinivas Murthy MD MASc FRCPC is the Health Research Foundation of Innovative Medicines Canada Chair in Pandemic Preparedness Research, and co-chair of the World Health Organizationโs (WHO) clinical research committee on COVID-19. He is an associate professor in the Faculty of Medicine at University of British Columbia, as well as a critical care and infectious diseases physician at B.C. Childrenโs Hospital in Vancouver. Murthyโs research focuses on infectious disease, clinical practice and clinical trials, and global health. He has also worked on the frontlines for a number of infectious disease outbreaks, including work on Ebola in Liberia, West Africa.
Dr.Alon Vaisman MD MAS FRCPC is an Infectious Diseases and Infection Control Physician at the University Health Network and the University of Toronto.
-
โ๐โ๐บ ๐ฑ๐ผ๐ป๐ฒ ๐๐ถ๐๐ต ๐๐ข๐ฉ๐๐โ ๐ถ๐ ๐ฒ๐ฎ๐๐ถ๐ฒ๐ฟ ๐๐ฎ๐ถ๐ฑ ๐๐ต๐ฎ๐ป ๐ฑ๐ผ๐ป๐ฒ-๐จ๐๐ ๐๐ ๐ท๐๐๐๐๐ , ๐ฎ๐๐๐๐ ๐๐๐ ๐ด๐๐๐ ๐ฑ๐๐.24๐๐ 2022
๐๏ธ๐๏ธ๐๏ธ ๐๐ฟ๐ผ๐บ ๐๐ข๐ฉ๐๐ ๐ฟ๐ฒ๐๐๐ฟ๐ถ๐ฐ๐๐ถ๐ผ๐ป๐ ๐ฎ๐ป๐ฑ ๐ถ๐บ๐ฝ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป๐ ๐ณ๐ผ๐ฟ ๐๐ต๐ฒ โ๐ป๐ฒ๐ ๐ ๐ป๐ผ๐ฟ๐บ๐ฎ๐นโ, ๐๐ผ ๐๐ต๐ฒ ๐ณ๐๐ป๐ฑ๐ฎ๐บ๐ฒ๐ป๐๐ฎ๐น ๐๐ต๐ถ๐ณ๐๐ ๐ถ๐ป ๐ฝ๐๐ฏ๐น๐ถ๐ฐ ๐ฎ๐๐๐ถ๐๐๐ฑ๐ฒ๐ ๐๐ผ๐๐ฎ๐ฟ๐ฑ๐ ๐ต๐ผ๐ ๐๐ฎ๐ป๐ฎ๐ฑ๐ถ๐ฎ๐ป ๐ต๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ ๐ถ๐ ๐ฑ๐ฒ๐น๐ถ๐๐ฒ๐ฟ๐ฒ๐ฑ, ๐ผ๐ป๐ฒ ๐ผ๐ณ ๐๐ฎ๐ป๐ฎ๐ฑ๐ฎ'๐ ๐จ๐ฆ ๐๐ผ๐ฝ ๐ต๐ฒ๐ฎ๐น๐๐ต ๐ฎ๐ป๐ฑ ๐ฝ๐๐ฏ๐น๐ถ๐ฐ ๐ฝ๐ผ๐น๐ถ๐ฐ๐ ๐ผ๐ฏ๐๐ฒ๐ฟ๐๐ฒ๐ฟ๐ ๐ฎ๐ป๐ฑ ๐ฐ๐ผ๐บ๐บ๐ฒ๐ป๐๐ฎ๐๐ผ๐ฟ๐, ๐๐ป๐ฑ๐ฟรฉ ๐ฃ๐ถ๐ฐ๐ฎ๐ฟ๐ฑ ๐ท๐ผ๐ถ๐ป๐ ๐๐ ๐ถ๐ป ๐๐๐๐ฑ๐ถ๐ผ.
๐ฐ ๐ช๐ฒ ๐ฒ๐ ๐ฝ๐น๐ผ๐ฟ๐ฒ ๐๐ต๐ถ๐ณ๐๐ ๐ถ๐ป ๐ท๐ผ๐๐ฟ๐ป๐ฎ๐น๐ถ๐๐บ ๐ฎ๐ป๐ฑ ๐๐ต๐ฒ ๐ฟ๐ผ๐น๐ฒ ๐ผ๐ณ ๐๐ต๐ฒ ๐บ๐ฒ๐ฑ๐ถ๐ฎ ๐ฑ๐๐ฟ๐ถ๐ป๐ด ๐ฎ ๐ฝ๐ฎ๐ป๐ฑ๐ฒ๐บ๐ถ๐ฐ, ๐ฎ๐ ๐๐ฒ๐น๐น ๐ฎ๐ ๐ฝ๐ผ๐ธ๐ฒ ๐๐ต๐ฒ ๐ฝ๐ฒ๐ฟ๐ฒ๐ป๐ป๐ถ๐ฎ๐น ๐ฝ๐๐ฏ๐น๐ถ๐ฐ ๐๐.(๐ผ๐ฟ ๐ฎ๐ป๐ฑ) ๐ฝ๐ฟ๐ถ๐๐ฎ๐๐ฒ ๐ฑ๐ฒ๐ฏ๐ฎ๐๐ฒ ๐ถ๐ป ๐ต๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ.
๐๐๐ก๐๐ผ๐ ๐ฑ๐ผ๐ฒ๐ ๐๐ป๐ฑ๐ฟรฉ ๐ฎ๐ฝ๐ฝ๐ฟ๐ผ๐ฎ๐ฐ๐ต ๐ต๐ถ๐ ๐ฝ๐ถ๐ฒ๐ฐ๐ฒ๐ ๐ถ๐ป ๐๐ต๐ฒ ๐๐น๐ผ๐ฏ๐ฒ ๐ฎ๐ป๐ฑ ๐ฑ๐ผ๐ฒ๐ ๐ต๐ฒ ๐ฒ๐๐ฒ๐ฟ ๐ต๐ฎ๐๐ฒ ๐๐ฟ๐ถ๐๐ฒ๐ฟโ๐ ๐ฏ๐น๐ผ๐ฐ๐ธ?
๐๐๐ข๐จ๐ง ๐๐ป๐ฑ๐ฟรฉ ๐ฃ๐ถ๐ฐ๐ฎ๐ฟ๐ฑ
Andrรฉ Picard is one of Canada's top health and public policy observers and commentators. Currently the health columnist at The Globe and Mail, he has been a staff writer for over 30 years. Picard is also the author of five books and has received acclaim for his writing and for his dedication to improving health care. In 2010, he was awarded a National Newspaper Award as Canada's top newspaper columnist.
-
Dr.Brian Conway, MD, FRCPC Infectious Disease Physician
Medical Director - Vancouver Infectious Diseases Centre (VIDC)
Dr. Brian Conway is the Medical Director of the Vancouver Infectious Diseases Centre (VIDC), specializing in the diagnosis and treatment of chronic infectious diseases and related conditions, with a focus on HIV and HCV infections. At VIDC, he is the Principal Investigator for over 25 HIV and HCV clinical research trials, and is credited with the conceptualization and implementation of the ENTENTE (Engage, Test, Engage, Treat, Engage) program that led to the development of VIDCโs Community Pop-Up Clinics (CPCs).
The VIDCโs CPCs provide point-of-care testing for HIV and HCV in Vancouverโs Downtown East Side (DTES). Over 500 patients have been diagnosed with HCV and engaged in care through this program, and over 150 have already received HCV treatment. His leadership with the CPCs has led to the development of novel strategies for the delivery of care emphasizing the simplification of therapeutic options and integration of medical, addiction, social, and psychological aspects of care.
Recent Media:
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized PatientsCOVID-19: B.C. should be prepared to abandon six-month wait for booster, Dr. Brian ConwayMedical experts weigh in on new COVID measures brought in by B.C. government.Canucks and COVID: Omicron virus variant vigilance vital for NHL, says diseases centre doc -
Dr.Santa Ono
President and Vice-Chancellor - University of British ColumbiaSanta J. Ono PhD FRSC FCAHS is the 15th President & Vice-Chancellor of the University of British Columbia.
Installed as President and Vice-Chancellor in 2016, he also serves as Chair of the U15 Group of Universities, on the Board of Directors of Universities Canada, and as Past Chair of Research Universities of British Columbia. He is also a member of the Boards of Fulbright and MITACS. He has also served on the Boards of the American Council on Education and the Council on Competitiveness and as Chief Innovation Advisor to the Province of British Columbia.
Prior to his appointment as President and Vice-Chancellor of UBC, Dr. Ono served as the 28th President of the University of Cincinnati and Senior Vice-Provost and Deputy to the Provost at Emory University.
He was appointed by Governor John Kasich to lead Ohioโs Biopharmaceutical Task Force and to the Board of the Ohio Third Frontier โ Ohioโs technology-based economic development program, when he served as President of the University of Cincinnati.
A molecular immunologist educated at the University of Chicago and McGill, Dr. Ono has taught at Johns Hopkins, Harvard University and University College London. He has advised national and regional governments on higher education and mental health. He has also advised companies such as GSK, Johnson & Johnson, Merck and Novartis on R&D.
He has served on a number of editorial boards, including Immunology, The Journal of Biological Chemistry, The Journal of Immunology and The Journal of Allergy & Clinical Immunology.
Dr. Ono has been inducted as a Fellow of the American Association for the Advancement of Science, the Canadian Academy of Health Sciences, the National Academy of Inventors, USA and the Johns Hopkins Society of Scholars.
He holds Honorary Doctorates from Chiba University and the Vancouver School of Theology and is a recipient of the Reginald Wilson Diversity Leadership Award from the American Council on Education, the Professional Achievement Award from University of Chicago, a Grand Challenges Hero Award from UCLA and the NAAAP 100 Award from the National Association of Asian American Professionals.
Listen to the Blue and Gold Podcast with Professor OnoThe National Forum on Anti-Asian Racism Final Report: https://events.ubc.ca/wp-content/uploads/2021/10/UBC-National-Forum-Anti-Asian-Racism-Report_18-Oct-2021_web.pdf -
Dr. Katharine Smart, CMA President
Dr. Katharine Smart is a pediatrician in Whitehorse, Yukon. Her work is centered on developing collaborative partnerships with community and government services to serve marginalized children using a model of social pediatrics. She works primarily with children who have experienced trauma and adverse childhood events, and she witnesses the broad and lasting impact these events have on children and their development daily. She is passionate about improving services for marginalized children in an effort to change their life trajectory.
In addition to her community-based work, Dr. Smart enjoys acute care and provides on-call services to the hospital. Before moving to the Yukon, she was a pediatric emergency medicine physician at the Alberta Childrenโs Hospital in Calgary. Dr. Smart is the past president of the Yukon Medical Association.
- Daha fazla göster
